$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Nov 5, 2025)
$138.51M
Market Cap
-
P/E Ratio
-0.66
EPS
$3.83
52 Week High
$0.22
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Purchase, New York, dedicated to pioneering small molecule therapies for age-related neurodegenerative diseases and retinal disorders. With a robust focus on enhancing cognitive health and vision in the aging population, the company is actively advancing its innovative pipeline through cutting-edge research and development initiatives. Cognition Therapeutics's proprietary drug design capabilities position it to offer transformative treatment options, addressing the growing demand for effective therapies in the rapidly expanding fields of neurodegeneration and age-related vision impairment.
ASST
NVDA
BYND
VHAI
PFE
SNAP
PLUG
TSLA
GRAB
F
PLTR
INTC
DNN
AMD
T
AAL
BITF
KVUE
CIFR
RXRX
SOFI
TEVA
SMCI
BAC
ADAP
NFE
AMCR
WBD
IREN
MARA
QS
VALE
DVLT
CAN
RIG
RGTI
U
WULF
FUBO
NVO
EPWK
BTBT
TLRY
NCLH
JOBY
RIOT
HIMS
NOK
APPS
CMG
HTZ
ALIT
HOOD
QBTS
KDLY
GOOGL
NIO
BW
NVTS
MU
HPE
AG
CPNG
HBAN
PBR
ITUB
PCG
MSPR
ASST
NVDA
BYND
VHAI
PFE
SNAP
PLUG
TSLA
GRAB
F
PLTR
INTC
DNN
AMD
T
AAL
BITF
KVUE
CIFR
RXRX
SOFI
TEVA
SMCI
BAC
ADAP
NFE
AMCR
WBD
IREN
MARA
QS
VALE
DVLT
CAN
RIG
RGTI
U
WULF
FUBO
NVO
EPWK
BTBT
TLRY
NCLH
JOBY
RIOT
HIMS
NOK
APPS
CMG
HTZ
ALIT
HOOD
QBTS
KDLY
GOOGL
NIO
BW
NVTS
MU
HPE
AG
CPNG
HBAN
PBR
ITUB
PCG
MSPR